Works matching Peter O'Donnell

Results: 764
    1
    2
    3
    4
    5
    6

    Bladder-Preserving Trimodality Therapy With Capecitabine.

    Published in:
    Clinical Genitourinary Cancer, 2024, v. 22, n. 2, p. 476, doi. 10.1016/j.clgc.2024.01.002
    By:
    • Lynch, Connor;
    • Sweis, Randy F.;
    • Modi, Parth;
    • Agarwal, Piyush K.;
    • Szmulewitz, Russell Z.;
    • Stadler, Walter M.;
    • O'Donnell, Peter H.;
    • Liauw, Stanley L.;
    • Pitroda, Sean P.
    Publication type:
    Article
    7
    8
    9
    10
    11

    Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes.

    Published in:
    2019
    By:
    • Grivas, Petros;
    • Mortazavi, Amir;
    • Picus, Joel;
    • Hahn, Noah M.;
    • Milowsky, Matthew I.;
    • Hart, Lowell L.;
    • Alva, Ajjai;
    • Bellmunt, Joaquim;
    • Pal, Sumanta K.;
    • Bambury, Richard M.;
    • O'Donnell, Peter H.;
    • Gupta, Sumati;
    • Guancial, Elizabeth A.;
    • Sonpavde, Guru P.;
    • Faltaos, Demiana;
    • Potvin, Diane;
    • Christensen, James G.;
    • Chao, Richard C.;
    • Rosenberg, Jonathan E.
    Publication type:
    journal article
    12

    Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer: A report from the Bladder Cancer Advocacy Network Clinical Trials Working Group

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 11, p. 1994, doi. 10.1002/cncr.27973
    By:
    • Galsky, Matthew D.;
    • Hendricks, Ryan;
    • Svatek, Robert;
    • Bangs, Rick;
    • Hoffman‐Censits, Jean;
    • Clement, Jessica;
    • Dreicer, Robert;
    • Guancial, Elizabeth;
    • Hahn, Noah;
    • Lerner, Seth P.;
    • O'Donnell, Peter H.;
    • Quale, Diane Zipursky;
    • Siefker‐Radtke, Arlene;
    • Shipley, William;
    • Sonpavde, Guru;
    • Vaena, Daniel;
    • Vinson, Jacob;
    • Rosenberg, Jonathan
    Publication type:
    Article
    13
    14
    15
    16

    A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma.

    Published in:
    BJU International, 2014, v. 113, n. 5b, p. E137, doi. 10.1111/bju.12564
    By:
    • Pond, Gregory R.;
    • Agarwal, Neeraj;
    • Bellmunt, Joaquim;
    • Choueiri, Toni K.;
    • Qu, Angela;
    • Fougeray, Ronan;
    • Vaughn, David;
    • James, Nicholas D.;
    • Salhi, Yacine;
    • Albers, Peter;
    • Niegisch, Günter;
    • Galsky, Matthew D.;
    • Wong, Yu‐Ning;
    • Ko, Yoo‐Joung;
    • Stadler, Walter M.;
    • O'Donnell, Peter H.;
    • Sridhar, Srikala S.;
    • Vogelzang, Nicholas J.;
    • Necchi, Andrea;
    • Di Lorenzo, Giuseppe
    Publication type:
    Article
    17
    18

    Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33980-9
    By:
    • Damrauer, Jeffrey S.;
    • Beckabir, Wolfgang;
    • Klomp, Jeff;
    • Zhou, Mi;
    • Plimack, Elizabeth R.;
    • Galsky, Matthew D.;
    • Grivas, Petros;
    • Hahn, Noah M.;
    • O'Donnell, Peter H.;
    • Iyer, Gopa;
    • Quinn, David I.;
    • Vincent, Benjamin G.;
    • Quale, Diane Zipursky;
    • Wobker, Sara E.;
    • Hoadley, Katherine A.;
    • Kim, William Y.;
    • Milowsky, Matthew I.
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27

    The Best-Laid Plans...

    Published in:
    Applied Clinical Trials, 2013, v. 22, n. 4, p. 22
    By:
    • O'Donnell, Peter
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50